The University of Chicago Header Logo

Connection

Demet Arac-Ozkan to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Demet Arac-Ozkan has written about Drug Evaluation, Preclinical.
Demet Arac-Ozkan
Connection Strength
0.082
Drug Evaluation, Preclinical
  1. A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate. Structure. 2008 Oct 08; 16(10):1588-97.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.